Gary L. Kunz

Array ( [id] => 3816666 [patent_doc_number] => 05770582 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Pharmaceutical compositions containing deoxyribonucleosides for wound healing' [patent_app_type] => 1 [patent_app_number] => 8/419767 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7809 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770582.pdf [firstpage_image] =>[orig_patent_app_number] => 419767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3941295 [patent_doc_number] => 05981597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Differentiating agents for the treatment of inflammatory intestinal diseases' [patent_app_type] => 1 [patent_app_number] => 8/413806 [patent_app_country] => US [patent_app_date] => 1995-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3810 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981597.pdf [firstpage_image] =>[orig_patent_app_number] => 413806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686226 [patent_doc_number] => 05643767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Process for isolating cellular components' [patent_app_type] => 1 [patent_app_number] => 8/412388 [patent_app_country] => US [patent_app_date] => 1995-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 7357 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643767.pdf [firstpage_image] =>[orig_patent_app_number] => 412388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1399534 [patent_doc_number] => 06541610 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Fusion proteins comprising tumor necrosis factor receptor' [patent_app_type] => B1 [patent_app_number] => 08/406824 [patent_app_country] => US [patent_app_date] => 1995-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 28026 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541610.pdf [firstpage_image] =>[orig_patent_app_number] => 08406824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047224 [patent_doc_number] => 05908926 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => '5\'to 3\' nucleic acid synthesis using 3\'-photoremovable protecting group' [patent_app_type] => 1 [patent_app_number] => 8/406327 [patent_app_country] => US [patent_app_date] => 1995-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5078 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908926.pdf [firstpage_image] =>[orig_patent_app_number] => 406327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047814 [patent_doc_number] => 05869461 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Reducing toxicity of L-nucleosides with D-nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/406198 [patent_app_country] => US [patent_app_date] => 1995-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7511 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869461.pdf [firstpage_image] =>[orig_patent_app_number] => 406198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625674 [patent_doc_number] => 05608047 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Cyclic ADP-ribose and analogs' [patent_app_type] => 1 [patent_app_number] => 8/404467 [patent_app_country] => US [patent_app_date] => 1995-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 3101 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/608/05608047.pdf [firstpage_image] =>[orig_patent_app_number] => 404467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3573608 [patent_doc_number] => 05539098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => '5\'-O-propionyl and 5\'-O-butyryl esters of 2-amino-6-methoxy-9-(.beta.-D-arabinofuranosyl)-9H-purine' [patent_app_type] => 1 [patent_app_number] => 8/403363 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17752 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/539/05539098.pdf [firstpage_image] =>[orig_patent_app_number] => 403363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659026 [patent_doc_number] => 05623068 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Synthesis of DNA using substituted phenylacetyl-protected nucleotides' [patent_app_type] => 1 [patent_app_number] => 8/396993 [patent_app_country] => US [patent_app_date] => 1995-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20456 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/623/05623068.pdf [firstpage_image] =>[orig_patent_app_number] => 396993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3429698 [patent_doc_number] => 05463035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-31 [patent_title] => 'Process for purifying pentostatin' [patent_app_type] => 1 [patent_app_number] => 8/396443 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1880 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/463/05463035.pdf [firstpage_image] =>[orig_patent_app_number] => 396443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3620963 [patent_doc_number] => 05688774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'A.sub.3 adenosine receptor agonists' [patent_app_type] => 1 [patent_app_number] => 8/396111 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23464 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688774.pdf [firstpage_image] =>[orig_patent_app_number] => 396111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3925059 [patent_doc_number] => 05914396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => '2\'-O-modified nucleosides and phosphoramidites' [patent_app_type] => 1 [patent_app_number] => 8/373298 [patent_app_country] => US [patent_app_date] => 1995-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24592 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914396.pdf [firstpage_image] =>[orig_patent_app_number] => 373298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3507052 [patent_doc_number] => 05569680 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-29 [patent_title] => 'Method of treating inflammatory bowel disease with tributyrin' [patent_app_type] => 1 [patent_app_number] => 8/387116 [patent_app_country] => US [patent_app_date] => 1995-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2908 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/569/05569680.pdf [firstpage_image] =>[orig_patent_app_number] => 387116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3117755 [patent_doc_number] => 05449773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-12 [patent_title] => 'Platinum complexes of sucrose derivatives' [patent_app_type] => 1 [patent_app_number] => 8/377220 [patent_app_country] => US [patent_app_date] => 1995-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12363 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/449/05449773.pdf [firstpage_image] =>[orig_patent_app_number] => 377220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3474079 [patent_doc_number] => 05476930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-19 [patent_title] => 'Non-enzymatic ligation of oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/376688 [patent_app_country] => US [patent_app_date] => 1995-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 10 [patent_no_of_words] => 3701 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/476/05476930.pdf [firstpage_image] =>[orig_patent_app_number] => 376688 [rel_patent_id] =>[rel_patent_doc_number] =>)